The rise of private wealth as a source of capital could be teeing up a new wave of conflicts between LPs and GPs. What are the considerations when evergreen funds invest alongside institutional capital? What does it mean if evergreens become more widely adopted by the institutional market? How should LPAs evolve and what is the best advice for how should GPs and LPs engage?
